Prevention of Retinal Detachment

Retinal Reattachment: General Surgical Principles and Techniques

Prevention of Retinal Detachment C. P. Wilkinson

Section 2 Chapter

106 

INTRODUCTION Rhegmatogenous retinal detachment continues to be an important cause of reduced visual acuity and blindness. In consecutive series, initial surgical attempts to reattach the retina currently fail in approximately 10–20% of cases, and reoperations are unsuccessful in as many as 5% of cases.1–3 Anatomical success is significantly less common in consecutive series of eyes with features suggesting an increased risk of proliferative vitreoretinopathy (PVR).4 Following anatomically successful surgery, visual acuity returns to 20/50 or better in only approximately 50% of cases.5 Thus, the prevention of retinal detachment is a worthy goal, and a variety of prophylactic methods have been investigated since Jules Gonin, in 1920, first identified the pathogenesis and treatment of this previously incurable disorder. However, despite a long-standing interest in the ophthalmologic community regarding prophylactic therapy, there have been no optimal clinical trials to test the legitimate value of any form of preventive treatment.6–8 Vitreous liquefaction and a retinal break are prerequisites for rhegmatogenous retinal detachment, and the usual pathologic sequence is vitreous liquefaction followed by some degree of posterior vitreous detachment (PVD). This results in vitreoretinal traction at the site of a vitreoretinal adhesion and in the production of a retinal tear (Fig. 106.1). Alternatively, traction may be exerted upon areas of lattice degeneration containing atrophic retinal holes. Continued vitreoretinal traction near retinal breaks appears to be necessary to cause the vast majority of clinical retinal detachments. Thus, retinal detachment might be avoided by: (1) preventing vitreous liquefaction and associated PVD; (2) relieving vitreoretinal traction; or (3) creating a chorioretinal adhesion around vitreoretinal adhesions and retinal breaks. No means are available to prevent vitreous liquefaction and later PVD in most eyes, although maintaining an intact posterior lens capsule after extracapsular cataract surgery may reduce or delay these changes.9,10 Vitreoretinal traction can be relieved by vitrectomy or by scleral buckling. However, prophylactic vitrectomy is not performed because there are technical difficulties in completely removing the peripheral vitreous gel, and it is relatively hazardous. Scleral buckling is only rarely employed, such as in particularly high-risk cases in which a nontraumatic giant retinal tear has already occurred in a fellow eye11 or in cases of posterior segment open globe injuries.12 Thus, the primary method of preventing retinal detachment involves the use of laser photocoagulation or cryotherapy to create a chorioretinal adhesion around both visible sites of vitreoretinal adhesion and retinal breaks. Although this is frequently successful in sealing

Fig. 106.1 Traction on the retina (arrowhead) at a site of abnormal vitreoretinal adhesion has created a retinal tear. If left untreated, liquid vitreous posterior to the vitreous gel will pass through this retinal break into the subretinal space, creating a retinal detachment. Operculated tears typically no longer have traction forces upon them (dark arrow) unless there is a nearby vitreoretinal adhesion. (Reprinted from Brinton D, Wilkinson CP. Retinal detachment: Principles and practice. 3rd ed. New York: Oxford University Press with the cooperation of the American Academy of Ophthalmology. © 2009, with permission from Oxford University Press.)

the treated lesion and preventing it from causing a clinical retinal detachment, the genuine value of such therapy related to simple observation remains unclear in most situations, since most visible asymptomatic retinal breaks and vitreoretinal degenerative lesions do not cause retinal detachments. Instead, breaks causing detachment usually occur in regions of the peripheral retina that appear normal before PVD.6,7 In addition, relatively extensive prophylactic therapy may cause vitreous changes that actually increase the chances of subsequent vitreoretinal traction and retinal detachment.6,13

Surgical Retina

Retinal Reattachment: General Surgical Principles and Techniques

Section 2

1794

RISK FACTORS FOR RETINAL DETACHMENT In any eye with visible retinal breaks or vitreoretinal adhesive lesions that predispose to retinal detachment, a number of additional factors are considered to be associated with a relatively high risk of subsequent retinal detachment (Table 106.1). Symptoms and signs of acute PVD place an eye at particularly high risk. Additional factors include a variety of hereditary, congenital, acquired, and iatrogenic problems. In evaluating the natural history or risk of retinal detachment in these cases, particular attention must be paid to the way in which both natural history and postoperative data, regarding a variety of retinal lesions, have been collected. The risk of retinal detachment is substantially different among subgroups of eyes, a fact that influences interpretation of both natural history data and treatment results. For example, since an acute PVD is the primary cause of most retinal detachments, and since most retinal tears occur during or soon after PVD, it is likely that eyes without a PVD have a higher risk of later retinal detachment than eyes with a history of prior PVD and no subsequent retinal breaks, regardless of additional risk factors.14 Similarly, vitreous liquefaction and PVD occur with greater frequency in older patients and in myopic and nonphakic eyes.15 Thus, data regarding lesions in otherwise normal, young, nonmyopic eyes are not comparable with data from cases with other risk factors that greatly increase the likelihood of PVD. Since more than one factor is often present, data analysis is difficult if all features are not recorded. For example, myopic aphakic eyes with lattice degeneration and with a history of retinal detachment in the fellow eye have a substantially greater risk of retinal detachment than otherwise normal eyes with lattice degeneration. No prospective randomized trials of therapy to prevent retinal detachment have been performed.6–8 The few published studies of treated and untreated comparable eyes have been retrospective, and most reports regarding prophylactic therapy have simply described results of a treatment series. This chapter briefly discusses published outcomes regarding both the natural course of lesions that predispose an eye to

Table 106.1 Risk factors for rhegmatogenous retinal detachment Hereditary/congenital/developmental/degenerative Male gender Hereditary vitreoretinopathies Myopia Lattice degeneration Cystic retinal tuft Degenerative retinoschisis Retinal breaks Prior ocular surgery Aphakia/pseudophakia Nd:YAG posterior capsulotomy Other surgery involving vitreous gel Prior ocular trauma Inflammatory CMV retinitis Acute retinal necrosis Other Fellow-eye nontraumatic retinal detachment

retinal detachment and results of prophylactic therapy for these retinal breaks and vitreoretinal adhesive lesions. The topic of “subclinical retinal detachment” (for definition, see Fig. 106.4) will not be discussed as a separate entity because of the nonspecific nature of the term. This chapter distinguishes symptomatic from asymptomatic cases and is organized according to the type of retinal break or vitreoretinal adhesive disorder and also according to the presence of other high-risk factors. A brief discussion of treatment methods precedes the review of treatment results and complications.

SYMPTOMATIC EYES Patients are considered symptomatic if they describe photopsia and/or increased vitreous floaters associated with an acute posterior vitreous detachment. Approximately 15% of eyes with a symptomatic PVD develop retinal tears of various types.16–18 The risk of retinal tears is directly related to the amount of vitreous hemorrhage associated with symptoms, and the finding of pigmented cells in the vitreous is a sign associated with a particularly high chance of associated retinal tear(s).19 In symptomatic eyes, retinal tears associated with persistent vitreoretinal traction are especially likely to cause retinal detachment, and the likelihood is even higher in cases with additional high-risk factors. Retinal tears resulting from a symptomatic PVD should be distinguished from pre-existing retinal breaks detected after the PVD but not caused by it. Thus, atrophic retinal holes within areas of lattice degeneration are not considered “symptomatic,” even if they were first observed during an examination prompted by symptoms of an acute PVD. Symptomatic retinal tears are subdivided into those with persistent vitreoretinal traction and those in which all traction in the region of the retinal defect has disappeared (Fig. 106.1).

Tears with persistent vitreoretinal traction Most symptomatic tears with persistent vitreoretinal traction are horseshoe-shaped and have a high risk of causing clinical retinal detachment. Rarely, a retinal tear with a free operculum may have persistent vitreoretinal traction as a result of a residual vitreoretinal adhesion near the retinal break, most frequently at the location of a retinal blood vessel (Fig. 106.2).

Horseshoe-shaped tears Untreated symptomatic retinal tears with persistent vitreoretinal traction have been reported to cause retinal detachment in

Fig. 106.2 Superior temporal retinal detachment, left eye, resulting from a single operculated retinal break. The minimal movement of the operculum during major ocular saccades indicated that persistent vitreoretinal adhesions were present in the vicinity of the retinal hole.

Table 106.2 Progression of symptomatic retinal breaks to retinal detachment (RD) Cases (n)

RD (%)

Treated horseshoe-shaped tears

Shea et al. 197420

48

4.2

Robertson and Priluck 197913

88

7.8

Verdaguer and Vaismon 197921

74

5.4

Pollack and Oliver 198122

74

1.4

Colyear and Pischel 196023

20

55

Shea et al. 197420

21

48

Treated operculated breaks

Robertson et al. 198124

47

0

Untreated operculated breaks

Colyear and Pischel 196023

22

4.5*

Untreated horseshoe-shaped tears

Davis 197325

6

17*

*A single break in each series exhibited persistent vitreoretinal traction upon a nearby retinal vessel and caused a subsequent retinal detachment.

33–55% of cases (Table 106.2). Treatment of this type of break substantially reduces the risk of retinal detachment (Table 106.2),20 and immediate therapy for these lesions is indicated to prevent an accumulation of subretinal fluid.7,26 A chorioretinal adhesion is created in flat retina immediately adjacent to localized subretinal fluid (Fig. 106.3). Reviews of treatment techniques have been provided elsewhere in the literature,27 and these are briefly discussed later in this chapter.

Round tears The percentage of operculated retinal tears that are associated with persistent vitreoretinal traction in the vicinity of the retinal break is unknown, but it is quite low. Only two symptomatic operculated retinal breaks have been reported to progress to retinal detachment, and both were associated with persistent vitreoretinal traction on a nearby retinal vessel.23,25 In unusual cases in which an operculated retinal hole is the only retinal break associated with a clinical retinal detachment, it is presumed that anomalous persistent vitreoretinal adhesions are located in the vicinity of the retinal tear (Fig. 106.2). Failures following treatment of operculated retinal holes have not been reported (Table 106.1).

Tears unassociated with persistent vitreoretinal traction Symptomatic operculated retinal tears unassociated with persistent vitreoretinal traction in the vicinity of the retinal break have not been reported to progress to clinical retinal detachment (Table 106.1). Similarly, although large numbers of these breaks have been treated prophylactically, there are no reports in the literature of a treatment failure (Table 106.1). Treatment of this

1795 Chapter 106

Authors

Prevention of Retinal Detachment

Type of break

Fig. 106.3 Cryotherapy is placed to surround and demarcate a peripheral, symptomatic, horseshoe-shaped tear with a subclinical retinal detachment. Photocoagulation can often be applied around the posterior portion of the detachment, but cryotherapy may be needed anteriorly if laser treatment cannot be extended into the vitreous base. (From Brinton D, Wilkinson CP. Retinal detachment: Principles and practice. 3rd ed. New York: Oxford University Press with the cooperation of the American Academy of Ophthalmology. © 2009, with permission from Oxford University Press.)

type of retinal break appears to be unnecessary unless the possibility of persistent vitreoretinal traction cannot be excluded.

Retinal holes and precursors of retinal detachment Eyes with symptoms and signs of acute PVD frequently contain atrophic retinal breaks that are not due to acute vitreoretinal traction. For the purposes of this discussion, these lesions are considered to be pre-existing and not symptomatic.17 Similarly, precursors of retinal detachment, including lattice degeneration, cystic retinal tufts, and age-related retinoschisis, are managed as if they were originally discovered in asymptomatic eyes.

ASYMPTOMATIC EYES WITHOUT HIGH-RISK FACTORS Nonmyopic phakic eyes in patients without a family history of retinal detachment and without previous nontraumatic retinal detachment in the fellow eye are unlikely to develop retinal detachment, regardless of the presence of vitreoretinal pathology. Nevertheless, prophylactic therapy has sometimes been recommended to treat visible precursors of retinal detachment or retinal breaks.

Vitreoretinal precursors of retinal breaks Important precursors of retinal breaks and detachment include lattice degeneration, cystic retinal tufts, and degenerative retinoschisis. Of these, lattice degeneration is clearly the most

Lattice degeneration

Surgical Retina

Retinal Reattachment: General Surgical Principles and Techniques

Section 2

1796

important. Both lattice degeneration and cystic retinal tufts can be sites of retinal tears resulting from vitreoretinal traction at the time of PVD. Atrophic retinal holes commonly occur within areas of lattice degeneration and also in the outer layers of degenerative retinoschisis. However, these holes are a relatively infrequent cause of progressive retinal detachment. Lattice degeneration is present in approximately 30% of retinal detachments, and approximately 94% of these detachments occur in primary (nonfellow) eyes.6 Because lattice lesions are visible and occur in approximately 8% of the population, they have commonly been considered as candidates for prophylactic therapy. However, Byer’s natural history study of 276 patients and 423 involved eyes, followed an average of almost 11 years, indicated that lattice lesions in phakic nonfellow eyes were not particularly dangerous.28 At the end of the follow-up period, atrophic retinal holes were present in 150 (35%) eyes. Subclinical retinal detachments, defined as subretinal fluid extending more than one disc diameter (DD) from the break but not posterior to the equator (Fig. 106.4), were observed in ten of the eyes with holes. In six of these eyes, the subclinical detachment developed during the observation period, whereas four eyes exhibited the changes at the initial examination. Only one subclinical detachment was considered in need of treatment after a small asymptomatic posterior extension of subretinal fluid. Four asymptomatic tractional retinal tears were observed in three of these 423 eyes at the initial examination,

and symptomatic tractional tears without clinical detachment developed in five additional eyes during follow-up periods of 1.5–18 years.28 Three of five symptomatic and all asymptomatic breaks occurred adjacent to lattice lesions. All symptomatic breaks were successfully treated; no asymptomatic tractional tears were treated, and none changed over follow-up periods of 7, 10, and 15 years. Clinical retinal detachments developed in three of the 423 eyes.28 Two were due to round retinal holes in lattice lesions of patients in their mid-20s, and one was due to a symptomatic tractional tear. These figures clearly indicate that patients with lattice degeneration in a phakic nonfellow eye should not be treated prophylactically unless symptoms occur. However, retinal detachments associated with vitreoretinal traction upon lattice lesions containing atrophic retinal holes are relatively common in eyes with significant amounts of myopia.29,30 A discussion regarding self-examination of peripheral visual fields and periodic follow-up examinations are in order in myopic patients to reduce chances of macular involvement by slowly progressive detachments resulting from round holes in lattice lesions.

Cystic retinal tufts Retinal tears at sites of cystic retinal tufts may be responsible for as many as 10% of clinical retinal detachments associated with posterior vitreous detachment,31 and they are also associated with asymptomatic small horseshoe-shaped tears and minimal subretinal fluid in the absence of PVD.32 Byer31 calculated the chances of clinical retinal detachment in eyes with cystic retinal tufts to be one in 357, and these lesions are not worthy of prophylactic therapy in otherwise normal eyes.

Degenerative retinoschisis Clinical retinal detachments occur in association with degenerative retinoschisis in up to 6% of consecutive detachment cases,33 and the presence of retinoschisis and outer layer breaks has sometimes been considered an indication for prophylactic therapy.34 However, a natural course study of 218 eyes in 123 patients demonstrated no clinical retinal detachments during a follow-up period averaging 9.1 years.33 The vast majority of small subclinical detachments that develop in association with outer layer breaks remain small, and prophylactic therapy is indicated only in the presence of obvious significant progression of subretinal fluid posterior to the equator.

Asymptomatic retinal breaks

Fig. 106.4 Subclinical detachments are defined as those with fluid extending more than one disc diameter on all sides of the retinal break, but the detachment does not extend posterior to the equator. (From Brinton D, Wilkinson CP. Retinal detachment: Principles and practice. 3rd ed. New York: Oxford University Press with the cooperation of the American Academy of Ophthalmology. © 2009, with permission from Oxford University Press.)

In phakic nonfellow eyes, asymptomatic retinal breaks that are routinely discovered during an evaluation of the peripheral retina are extremely unlikely to lead to clinical retinal detachment, even if they are flap tears and even if posterior vitreous detachment occurs.35 During a follow-up period averaging 11 years, asymptomatic retinal breaks in 235 eyes of 196 patients were studied, and horseshoe-shaped tears were present in 45 cases. Acute PVD occurred in nine eyes without adversely affecting the pre-existing breaks, although new horseshoe-shaped tears developed in three cases, and these were promptly treated. Subclinical retinal detachments were observed in 19 (8%) eyes. Modest extension of subretinal fluid required therapy in two of these cases, and in a third case, a peripheral clinical retinal detachment slowly developed after 14 years of observation. Prophylactic therapy for asymptomatic retinal breaks in phakic nonfellow eyes is usually not recommended. An occasionally

Myopia and previous cataract extraction are considered as additional risk factors in patients with vitreoretinal lesions believed to predispose a nonfellow eye to retinal detachment. In addition, a positive family history for retinal detachment is considered important by some authors. The existence of any of these factors in nonfellow eyes has been associated with an increased enthusiasm for prophylactic therapy, despite the absence of appropriate supporting data.

Myopic nonfellow eyes Myopia is obviously associated with an increased risk of retinal detachment, and there is a direct correlation between amount of myopia and rate of retinal detachment.37 Lattice degeneration associated with retinal holes did not correlate with degree of myopia in the natural course study of Byer,28 although most slowly progressive clinical retinal detachments associated with lattice degeneration and an absence of extensive posterior vitreous detachment occur in young myopic patients,29,30 as noted above. There appears to be no increased value for treatment of myopic eyes with lattice degeneration in nonfellow eyes, and it is noteworthy that the small favorable effect of preventive treatment of lattice lesions in phakic fellow eyes could not be demonstrated if the degree of myopia exceeded 6 diopters.38 Cystic retinal tufts and degenerative retinoschisis are not more common in myopic eyes, and prophylactic therapy is not recommended in the absence of a progressive subclinical detachment. Asymptomatic retinal breaks are more common in myopic eyes than in emmetropic or hyperopic cases.5 However, clinical retinal detachments in these cases are rare in the absence of new symptoms, and prophylactic treatment is usually not advised in nonfellow eyes.

Aphakic and pseudophakic nonfellow eyes Removal of the crystalline lens is associated with a substantial increase in the rate of later retinal tears and detachments,39 regardless of the method of cataract surgery, and this probably is due to vitreous changes in the nonphakic eye. An intact posterior lens capsule appears to be associated with a reduced rate of retinal detachment following cataract surgery, whereas Nd:YAG capsulotomy is clearly associated with an increased risk of subsequent detachment.9,10 The natural course of lattice degeneration in nonphakic nonfellow eyes is not well documented, and results of preventive treatment in these particular cases are not available. Similarly, meaningful information regarding cystic retinal tufts and degenerative retinoschisis has not been published. Treatment of these lesions in nonfellow eyes is not advised. Asymptomatic retinal breaks in nonfellow nonphakic eyes or eyes undergoing cataract surgery have sometimes been regarded as an indication for prophylactic therapy. However, Friedman et al.40 followed 18 retinal breaks in nonmyopic aphakic eyes for 3–7 years, and none detached. Hyams et al.41 studied 103 myopic

Family history of retinal detachment Heredity clearly influences the chances of retinal detachment, particularly in families with vitreoretinal degenerative disorders such as Stickler syndrome. Prophylactic therapy is frequently considered in these cases, particularly if retinal detachment has occurred in the primary eye. However, no studies have properly stratified the several high-risk factors associated with retinal detachment and evaluated the natural course and the effects of prophylactic therapy in patients with a familial predisposition to retinal detachment.

ASYMPTOMATIC PATIENTS WITH RETINAL DETACHMENT IN THE FELLOW EYE Pathologic vitreoretinal changes often occur bilaterally, and patients with retinal detachment in one eye have a significantly increased risk of retinal detachment in the other eye. This risk has been estimated as ranging from as low as 9% to as high as 40%.27 Thus attempts to prevent retinal detachment in the second eye have received considerable attention. Prospective randomized studies have not been performed, but retrospective data regarding precursors of retinal detachments and asymptomatic retinal breaks have been published. These can be further categorized as phakic and nonphakic fellow eyes.

Asymptomatic phakic fellow eyes Phakic fellow eyes have a lower risk of subsequent retinal detachment than comparable nonphakic eyes. Treatment has been considered for both vitreoretinal precursors of retinal detachment and asymptomatic retinal breaks.

Precursors of retinal breaks Lattice degeneration is three times more common in eyes in which a retinal detachment associated with lattice degeneration has occurred in the fellow eye than it is in the general population.6 Lattice degeneration has been the most frequently studied indication for prophylactic therapy in fellow eyes. The widely quoted study of Folk et al.38 retrospectively studied 388 consecutive cases, in which phakic retinal detachment associated with lattice degeneration occurred in one eye and lattice degeneration was present in the second eye. During an average follow-up period of over 7 years, new retinal breaks or detachments occurred in 31 (20%) untreated eyes (Table 106.3). New tears with retinal detachment developed in nine eyes (5.1%), and new tears without detachment developed in ten cases. In ten eyes, new holes developed within areas of lattice degeneration, and atrophic retinal breaks occurred in areas distant from lattice lesions in the remaining two cases. Folk et al.38 reported a reduction in the incidence of new retinal tears and detachments in eyes receiving prophylactic therapy for

1797 Chapter 106

ASYMPTOMATIC NONFELLOW EYES WITH HIGH-RISK FACTORS

aphakic eyes and discovered 25 asymptomatic retinal breaks in 19 eyes. Although six of the 25 were horseshoe-shaped tears, later retinal detachment occurred in no cases. More thorough reviews of the literature regarding the natural course of asymptomatic nonphakic retinal breaks and therapy for them have been published elsewhere,6,27 and there are not sufficient data to provide firm guidelines for management of asymptomatic retinal breaks in nonfellow eyes that are nonphakic or scheduled for cataract surgery. Treatment of horseshoe-shaped tears in these cases appears to be frequently recommended despite the lack of appropriate information in the literature.7,26

Prevention of Retinal Detachment

observed exception to this rule is an inferior retinal dialysis. These breaks can cause slowly progressive retinal detachments that frequently become symptomatic only after macular involvement.36

Surgical Retina

Retinal Reattachment: General Surgical Principles and Techniques

Section 2

1798

all lattice lesions (Table 106.3). New tears without detachment occurred in five (3.0%) of these fully treated eyes. Retinal detachment occurred in three additional eyes (1.8%), compared with 5.1% in the 151 untreated phakic fellow eyes. The small beneficial effect of treating all lattice lesions was apparent when follow-up periods of 3, 5, and 7 years were analyzed separately. The beneficial effect was statistically significant for all patient subgroups, except in eyes with myopia of 6 diopters or more and in eyes with both high myopia and more than 6 clock-hours of lattice degeneration. Importantly, in these subgroups, treatment did not reduce the risk of retinal tears or detachment. Conversely, no detachments occurred after full treatment in eyes with less than 6 clock-hours of lattice degeneration or with less than 1.25 diopters of myopia.

Table 106.3 Outcomes for phakic fellow eyes with lattice degeneration Group Untreated Partial treatment Full treatment

Eyes (n)

Detachment (%)

New tears (%)

151

5.9

12.6

73

6.8

16.4

164

1.8

4.9

(Reproduced with permission from Folk JC, Arrindell EL, Klugman MR. The fellow eye of patients with phakic lattice detachment. Ophthalmology 1989;96:72–9.)

In a subsequent evaluation of the same data, Folk et  al.42 reported that new horseshoe-shaped tears developed in areas unassociated with lattice degeneration in approximately 30% of treated cases, and Byer6 has estimated that as many as 58% of retinal detachments in eyes with lattice degeneration arise in areas that exhibit no visible vitreoretinal abnormalities (Fig. 106.5). Because of this reality, some surgeons have recommended prophylactic therapy featuring the production of laser or cryotherapy burns over 360° of the peripheral retina (Fig. 106.6).6,27 However, the precise indications, intraocular findings, long-term results, and complications of this form of therapy have not been thoroughly described, and remarkably different success rates have been reported. Haut et  al.43 described 109 phakic fellow eyes followed for a minimum of 5 years, and only one retinal detachment and two additional tears occurred posterior to the circumferential chorioretinal adhesion. However, in another study,44 retinal detachment occurred in five of 10 cases of Stickler syndrome within 15 months of 360° prophylactic therapy. Byer6 has tabulated and reviewed data from 15 reports advocating such treatment, and he concluded that this form of treatment appeared to be both ineffective in preventing subsequent detachment and dangerous in apparently aggravating vitreoretinal traction. The value of this form of therapy to prevent giant retinal tears and tears following vitrectomy and other procedures will be discussed in a separate section below. Studies of prophylactic therapy of lattice degeneration, with and without holes, in phakic fellow eyes have been of limited

Fig. 106.5 Acute rhegmatogenous retinal detachment occurring despite earlier prophylactic laser photocoagulation for lattice degeneration. Acute horseshoe-shaped tears causing the detachment occurred in an area that previously appeared normal. (From Brinton D, Wilkinson CP. Retinal detachment: Principles and practice. 3rd ed. New York: Oxford University Press with the cooperation of the American Academy of Ophthalmology. © 2009, with permission from Oxford University Press.)

Chapter 106

1799

Prevention of Retinal Detachment

Fig. 106.6 Nearly confluent ring of prophylactic laser photocoagulation in the equatorial and pre-equatorial zone. This type of treatment, popular in some locations, extends to the posterior margin of the vitreous base. (From Brinton D, Wilkinson CP. Retinal detachment: Principles and practice. 3rd ed. New York: Oxford University Press with the cooperation of the American Academy of Ophthalmology. © 2009, with permission from Oxford University Press.)

value because they have not been prospective and because important information has been missing from available retrospective analyses. In particular, the outcomes have not been studied as a function of the presence of a posterior vitreous detachment. Davis25 demonstrated that retinal detachments were unusual in phakic fellow eyes if a PVD was present at the time of the initial examination. Retinal detachments occurred in none of 33 such cases. However, if a PVD was not present, retinal detachment subsequently developed in 14 (13%) of 112 phakic fellow eyes with lattice lesions. Appropriate prospective trials will be required to assess properly the value of treating lattice degeneration in phakic fellow eyes. The relatively low incidence of retinal detachment in untreated cases, the frequency of new tears in normal-appearing retina, the apparent ineffectiveness of therapy in eyes with extensive lattice degeneration and high myopia, and the known success rate following treatment of symptomatic retinal tears and detachments indicate that prophylactic treatment is of limited value in these cases. The apparently modest treatment benefit following treatment of all lattice lesions may be of value in selected patients, such as those with a poor surgical result in the first eye, or in patients who are incapable of recognizing symptoms of vitreous and/or retinal detachment or who live in areas with limited access to ophthalmologic care. In addition, as noted above, myopic patients with atrophic holes in lattice lesions should be evaluated periodically and counseled about loss of peripheral vision, because slowly progressive retinal detachments can occur. Cystic retinal tufts are bilateral in only 6% of cases, so they are not a common cause of bilateral retinal detachment, and there are no data supporting the value of prophylactic therapy.

Degenerative retinoschisis is an unusual cause of progressive retinal detachment, but retinoschisis is both common and frequently bilateral. Thus, patients with both retinal detachment and retinoschisis in one eye frequently have retinoschisis in the fellow eye. An evaluation of the literature regarding prophylactic therapy for retinoschisis in phakic fellow eyes is very difficult because of a lack of complete information regarding the cases.27 In the unusual case in which outer layer retinal breaks have been responsible for retinal detachment in the first eye, and outer layer breaks and retinoschisis are present in the fellow eye, prophylactic therapy is frequently recommended.

Retinal breaks Asymptomatic retinal breaks in phakic second eyes of patients with previous retinal detachment are frequently cited as an indication for prophylactic therapy.27 Flap tears appear to be much more likely to cause retinal detachment than round or operculated retinal holes (Fig. 106.1).25,45 Merin et al.45 discovered retinal breaks in 186 (19%) of 966 fellow eyes, 28 of which (15%) later developed retinal detachment. Horseshoe-shaped tears were the cause of the detachment in 20 (71%) of the 28 eyes, whereas only 19% of breaks were flap tears in the 158 eyes that did not progress to retinal detachment. However, Hyams et al.41 followed ten untreated asymptomatic horseshoe-shaped tears in phakic fellow eyes, and no retinal detachments occurred. Deficiencies in prior reports have made it difficult to assess both the natural course of asymptomatic retinal breaks that are discovered on an examination of a fellow eye and the results of treatment of these lesions. Most of these breaks are round and located within areas of lattice degeneration, and these cases were discussed earlier. Data regarding therapy for asymptomatic horseshoe-shaped

Section 2

1800

tears in fellow eyes suffer from a lack of details, including the status of the vitreous gel and the relationship between the original retinal break and the cause of subsequent retinal detachment. An aggressive national program of routine treatment of all retinal breaks in fellow eyes did not reduce the prevalence of retinal detachment in Israel.46 Still, treatment of horseshoeshaped tears that are discovered in asymptomatic fellow eyes is sometimes recommended despite the absence of optimal supportive data.

Surgical Retina

Retinal Reattachment: General Surgical Principles and Techniques

Giant retinal tears Prophylactic treatment is frequently recommended in phakic fellow eyes in which a nontraumatic giant retinal tear has occurred in the first eye. Freeman11 followed 321 cases for 12 months to 29 years. New giant retinal tears occurred in 14 (4.4%) untreated eyes, 13 of which were highly myopic and had developed “high-risk features” of increased vitreous liquefaction, and “white-with-pressure” that increased in extent. In a report by Wolfensberger et al.,47 48 patients were evaluated following repair of a giant retinal tear in one eye and 360° cryotherapy of the second eye for a mean of 84 months. During the follow-up period, retinal detachment developed in three patients, and a retinal tear alone was observed in a fourth. Ang et al.48 subsequently described 360° cryotherapy to prevent giant retinal tear in Type 1 Stickler syndrome in a retrospective study. Most of the cases were phakic, and the results indicated that such treatment significantly reduced the risk of later retinal detachment. However, the results of this study were subsequently criticized49 because of methodology issues, and the ultimate answers regarding the value of this form of therapy will require more optimal studies.50

Asymptomatic aphakic and pseudophakic fellow eyes All eyes have an increased risk of retinal detachment after cataract extraction, and the risk for fellow eyes in patients with previous retinal detachment in the first eye has been estimated to be 14–41%.27 The chances of detachment would be expected to be higher if secondary YAG capsulotomy were required.9,10 Thus, prophylactic therapy has frequently been recommended for vitreoretinal lesions in fellow eyes that are nonphakic or that are scheduled to undergo cataract extraction.

Precursors of retinal breaks Of the precursors of retinal tears that have been considered for prophylactic therapy before or after cataract extraction, only lattice degeneration has been extensively studied, and reviews of the literature have been published.6,27 However, no prospective randomized studies have compared the natural course in these cases with outcomes following preventive treatment.7 As is true of phakic fellow eyes, a major problem in treating only visible pathology is the frequency of new retinal tears that develop in areas of the peripheral retina that appear normal (Table 106.4, Fig. 106.5). Although treatment of visible lesions appears to reduce the chances of retinal tears occurring at the treated site, the retinal detachments that frequently develop in these fellow eyes are not prevented by this focal therapy.51–53 Studies of prophylactic treatment of lattice degeneration in fellow nonphakic eyes have not been stratified on the basis of posterior vitreous detachment. Hovland14 demonstrated the critical importance of this variable by studying aphakic eyes of patients with aphakic retinal detachment in the primary eye. Retinal detachment subsequently occurred in one (2.3%) of 43 eyes with a PVD in the fellow eye. In the 40 eyes without a previous PVD, retinal detachment later occurred in eight eyes (21%). Similarly, Davis25 reported that retinal detachments occurred in five (24%) of 21 aphakic fellow eyes without an apparent PVD (absence of Weiss ring or clearly visible posterior cortical vitreous surface) at the initial examination, but detachments did not occur in 15 additional cases in which a PVD was initially present. However, as noted earlier, the risk–benefit ratio of this form of treatment in unoperated eyes remains unknown. Treatment of lattice lesions in nonphakic fellow eyes is frequently recommended,26 despite the lack of supportive data. In eyes in which a PVD has previously occurred, it is doubtful if therapy is particularly effective or necessary. The value of various forms of prophylactic treatment in eyes without PVD will remain debatable until appropriate trials are conducted. Cystic retinal tufts and degenerative retinoschisis are unusual causes of bilateral retinal detachment, and data discussing the importance of these entities following cataract surgery are not available. They are managed as discussed under “Asymptomatic phakic fellow eyes”, above.

Table 106.4 Treatment for aphakic fellow eyes Detachment Eyes

Tear in normal retina (%)

Tear at lesion site

n

(%)

n

n

0

0

–

12

16

10

83

2

Treated (n = 11)

2

18

2

100

–

No treatment (n = 23)

7

30

7

100

–

(%)

Initially aphakic (n = 90) Treated (n = 13) No treatment (n = 77)

– 17

Cataract surgery during the study (n = 34)

(Reproduced with permission from Benson WE, Grand MG, Okun E. Aphakic retinal detachment: management of the fellow eye. Arch Ophthalmol 1975;93:245–9.)

Giant retinal tears Aphakic fellow eyes in nontraumatic giant retinal tear cases have a high risk of retinal detachment. Prophylactic therapy has been recommended for fellow eyes of these patients if significant vitreous liquefaction and progressive “white-with-pressure” are observed10 or, alternatively, in all such cases.

PROPHYLACTIC THERAPY IN EYES UNDERGOING VITREORETINAL SURGERY As noted previously, because of the tendency for new retinal breaks to develop in areas of the retina that appear normal, 360° treatment (Fig. 106.6) has been advocated during various forms of vitreoretinal surgery.

During silicone oil removal in previously operated eyes In a nonrandomized retrospective study of eyes following vitrectomy and silicone oil installation, 360° laser therapy appeared to be of value following removal of the oil,54 a more recent prospective study55 demonstrated similar results in apparently comparable eyes following oil removal.

During primary vitrectomy for nonretinal detachment In a study of eyes undergoing primary vitrectomy for macular disorders, Koh and coworkers56 evaluated a consecutive series of 220 eyes in a retrospective analysis. Peripheral laser therapy had been applied in 115 cases, and they were compared with 105 allegedly comparable eyes that had not received laser retinopexy. Postoperative retinal detachment subsequently developed in 11.4% of the nontreated cases and in 3.5% of those that were treated. However, the eyes were not stratified on the basis of a pre-existing vitreous detachment, and 56 cases were lost to follow-up before 6 months.

During pneumatic retinopexy Tornambe57 has advocated 360° laser therapy to prevent later retinal detachment in cases undergoing primary pneumatic retinopexy for retinal detachment, and other authors have described this technique at meetings and in non-peer-reviewed publications. Treated cases have had a lower incidence of subsequent retinal detachments due to new breaks. Still, optimal prospective studies have not been performed.

Summary regarding therapy during vitreoretinal surgery The rationale of preventing later retinal detachment by creating a 360° adhesive bond in peripheral regions of the retina, where persistent vitreoretinal traction would be expected to occur following PVD and a variety of vitreoretinal surgical procedures, is attractive. However, the genuine value of such therapy will remain uncertain until better studies are performed.

1801 Chapter 106

Retinal breaks in nonphakic eyes of patients with a previous retinal detachment in the other eye appear to have a higher rate of detachment.27 Davis25 described asymptomatic retinal breaks in ten aphakic fellow eyes. Subsequent retinal detachments occurred in five of these cases. Four of the five breaks causing retinal detachment were horseshoe-shaped tears, and the type of the fifth break was not reported. The literature regarding the value of treating round holes unassociated with lattice lesions is not clear. Treatment can be expected to prevent retinal detachment resulting from the identified break but not detachment resulting from breaks in other areas of the retina. Treatment of asymptomatic horseshoe-shaped tears in aphakic fellow eyes and in fellow eyes scheduled to undergo cataract extraction is recommended despite the absence of supportive data.26

TREATMENT METHODS Treatment to prevent retinal detachment can be applied in several ways. Usually, chorioretinal adhesions are created around retinal tears or specific vitreoretinal abnormalities that are judged likely to be the site(s) of future retinal breaks. This can be combined with scleral buckling to further reduce vitreoretinal traction, although buckling is rarely used in the prevention of retinal detachment. The three methods currently available for creating chorioretinal adhesions are diathermy, photocoagulation, and cryotherapy. Diathermy is best applied with scleral dissection, a surgical technique that currently is very rarely employed to prevent retinal detachment. However, it can be used to treat localized subclinical detachments when combined with scleral buckling. Thus, treatment to prevent retinal detachment usually entails a choice between cryotherapy and laser photocoagulation. Photocoagulation was first performed using a xenon arc light source, but this has been replaced by laser photocoagulation. Cryotherapy and laser photocoagulation cause chorioretinal adhesions that seem equally effective in preventing retinal detachment, and choice of a treatment method depends on individual features of the case. Sometimes both methods are used in the same eye, because parts of one or more lesions can be treated best with one modality and other parts are treated best with the other (see Fig. 106.3).

Cryotherapy Cryotherapy is usually applied in a transconjunctival fashion, although it is sometimes necessary to open the conjunctiva and insert the probe in the episcleral space when treating posterior lesions. Visualization is provided by indirect ophthalmoscopy, and this combination is particularly effective in treating far anterior lesions and treating eyes with partial opacities of the ocular media, such as cataract changes or mild vitreous hemorrhage. Cryotherapy also has certain disadvantages, some of which are theoretical concerns. First, treatment with cryotherapy is difficult for far posterior lesions, unless an incision is created in the conjunctiva. Second, cryotherapy applications do not create an immediately visible effect; therefore, it may be difficult to be certain where the treatment was applied. This can result in areas that are skipped or in refreezing the same area. Third, cryotherapy may cause dispersion of viable pigment epithelial cells through the retinal break into the vitreous cavity, and the dispersion of cells may be increased if the same area is retreated. Therefore, applications should avoid the center of the retinal break. Cryotherapy also causes breakdown of the blood–retinal barrier, with leakage of serum proteins into the intraocular fluids, and some of the serum components are capable of causing later cellular migration. Cryotherapy applied over the long posterior ciliary nerves can impair accommodation for weeks or

Prevention of Retinal Detachment

Retinal breaks

1802

months. Finally, chorioretinal adhesions induced by cryotherapy are not as rapidly clinically effective as those that follow laser treatment.

Surgical Retina

Retinal Reattachment: General Surgical Principles and Techniques

Section 2

Laser photocoagulation Laser photocoagulation has several advantages as well as certain limitations and possible disadvantages. Laser applications cause an immediate visible reaction, which aids both in judging the biologic intensity of each application and in documenting the area of treatment. Each application is precisely focused so that the margins of the break and the surrounding retina can be treated without affecting the pigment epithelium within the open break. The laser applications produce a coagulative effect that seems to cause some immediate adhesion between the retina and pigment epithelium. Laser photocoagulation is usually applied with either a slitlamp delivery system using a fundus contact lens or an indirect ophthalmoscopic delivery system. Treatment at the slit lamp is best for posterior lesions. Treatment in the far periphery is considerably more difficult, depending on factors such as the amount of pupillary dilation, and it is sometimes impossible to photocoagulate lesions adequately in this region. Laser delivery systems coupled with binocular indirect ophthalmoscopy have significantly improved the ability to treat the peripheral retina with laser therapy. Routine scleral depression can be employed as laser burns are applied to the crest of the indented area. Considerable practice is necessary to produce burns which are as consistent in size and intensity as those which are created with a slit lamp and contact lens. The major disadvantages of laser treatment include the requirement for relatively clear media and adequate visualization of the lesion. Therefore, eyes with a small pupil or media opacities, such as partial cataract or mild vitreous hemorrhage, are not good candidates for laser treatment. The laser energy can also cause specific complications. Anterior segment burns involving the cornea and lens are probably more common during treatment with binocular indirect ophthalmoscopic laser delivery systems than when energy is applied via a slit lamp and contact lens. Excessive energy delivered in any fashion can cause rupture of Bruch’s membrane, choroidal hemorrhage, or even retinal hole formation. Laser treatment also causes some breakdown of the blood–retinal barrier, but this is not as significant as with cryotherapy.

Surgical techniques Treatment techniques vary according to the method selected and individual features of each case. However, the general objective is to create a zone of chorioretinal adhesion around each retinal break or area of vitreoretinal abnormality with minimal application of energy and with precise control under direct visualization. The treatment should cause little or no discomfort and should minimize potential complications.

Cryotherapy Cryotherapy is usually applied transconjunctivally using a combination of topical and subconjunctival anesthetic injection, reducing the risk of mechanical damage to the globe or optic nerve with a retrobulbar injection. Also, transconjunctival cryotherapy is easiest when the patient can rotate the eye on command to assist in visualization and to counteract the pressure applied to the globe by the cryoprobe.

The probe tip is properly oriented before being applied to the globe, so that the active surface is in direct contact with the eye wall. This prevents accidental freezing in the adjacent meridian. The eye is usually rotated toward the meridian to be treated as the probe is applied, and the probe is moved to indent the sclera beneath the retinal break or vitreoretinal abnormality. If the lesion is located posteriorly or the conjunctival fornix is shallow, the eye is rotated in the opposite direction, thereby permitting placement of the probe in a more posterior location. The cryoprobe is activated after being positioned beneath or adjacent to the retinal lesion. The freezing effect is permitted to progress until the retina just becomes involved, and then the application is terminated. With experience, the size and intensity of each freezing effect can be anticipated. The probe is moved to an adjacent location, and the freezing mechanism is reactivated. Usually the probe is moved to contiguous locations within the same field of view to minimize the risk of skipping an area or refreezing the same tissue. Some retinal lesions can be treated with a single application, whereas others require multiple applications. Large retinal breaks are surrounded by contiguous applications while avoiding freezing of the exposed pigment epithelium within the open break, thus preventing further dispersion of pigment epithelial cells into the vitreous cavity. Areas of lattice degeneration are also surrounded by multiple applications, with each application straddling the posterior and lateral margins of the lattice lesions where acute retinal tears are most likely. The area anterior to all retinal breaks with persistent vitreous traction is also treated, since progressive traction may cause anterior extension of the break (see Fig. 106.3). If relatively far posterior lesions must be treated, an incision in the conjunctival fornix is made. A supplemental subconjunctival anesthetic injection is given, the conjunctiva is incised with scissors, and dissection is performed in the episcleral space in that meridian. The posterior edge of the incision is grasped with forceps as the cryoprobe is introduced and positioned beneath the lesion. Closure of the conjunctival incision is usually unnecessary, but it can be closed with an absorbable suture. The patient is told that local swelling and subconjunctival hemorrhage are common after transconjunctival cryotherapy and not to be concerned about the external appearance of the eye. Patient postoperative activity is determined by the type of lesion treated. Normal activity is permitted after treatment of lattice degeneration without retinal breaks. Marked restriction of activity, sometimes including bedrest and bilateral bandages, may be appropriate after treatment of an acute retinal break with localized detachment, since an effective chorioretinal reaction may not be present for about 5 days.

Laser photocoagulation Laser photocoagulation is usually performed with topical anesthesia. The ability of the patient to move the eye on command is also helpful during photocoagulation to assist in visualization. The greatest difficulty may be in identifying the lesion to be treated when viewing through the slit lamp and fundus contact lens. With the slit lamp, a spot size of 200–500 µm is preferred, although a smaller spot size is used if diffraction caused by the ocular media results in significant divergence of the beam. With an indirect laser system, spot size at the laser source is predetermined, although the burn size in the retina can be modified with variations in employment of the condensing lens. A low-power

Scleral buckling A scleral buckling operation is rarely necessary as a prophylactic procedure, although it can be performed if there is prominent vitreoretinal traction and significant subretinal fluid and if a chorioretinal adhesion alone is thought to be insufficient in preventing subsequent clinical retinal detachment. Prophylactic scleral buckling is most commonly used to treat progressive subclinical detachments, and a radial scleral buckle is employed in most of these cases. When scleral buckling is used for only prophylactic purposes for extensive vitreoretinal pathology, an encircling buckle is usually required. This procedure is combined with a broad zone of cryotherapy or diathermy treatment extending from near the ora serrata to a location posterior to the posterior margin of the vitreous base or posterior to other specific areas of chorioretinal traction. The encircling buckling effect can be produced with a band 2.5–4 mm wide, or a band can be combined with a broader, grooved element. Sutures or scleral tunnels are used to secure the band to the sclera in the middle of each quadrant. Volume reduction can be difficult in these cases because the eye cannot be softened by drainage of subretinal fluid. Multiple anterior chamber paracenteses are often necessary, and the patient may also given intravenous acetazolamide and hyperosmotic agents.

RESULTS AND COMPLICATIONS OF PROPHYLACTIC THERAPY As noted in previous sections, no prospective randomized clinical trial has been performed to evaluate treatment of precursors of retinal tears and retinal breaks, and interpretation of existing treatment results is difficult because the natural course of the respective lesions is uncertain.7,26 In addition, available studies have not appropriately stratified important variables for comparison of subgroups. However, the most thorough natural course studies of lattice degeneration,28 degenerative retinoschisis,33 and asymptomatic retinal breaks6 demonstrate that these conditions rarely cause acute retinal detachment in patients without a previous retinal detachment in the fellow eye. Of all vitreoretinal lesions causing clinical retinal detachment, the natural course of symptomatic retinal tears with persistent vitreoretinal traction is best known, and there is agreement that prompt treatment of symptomatic horseshoe-shaped tears is

Results of prophylactic therapy Results of treatment to prevent retinal detachment are presented in Tables 106.2–106.4. The studies are all somewhat incomplete, as most do not describe information about important variables, including the refractive error, the status of the crystalline lens, the status of the posterior vitreous surface, the type of retinal breaks, and whether there had been a detachment in the fellow eye. In addition, longer-term (e.g., 5–10 years) follow-up information is lacking in most reports. In a 1991 study, Smiddy et al.58 demonstrated that new retinal breaks continued to occur long after initial prophylactic therapy. In symptomatic eyes that were treated, new retinal breaks were observed in 13%, 3 months after therapy and in 21%, 2 years postoperatively. The outcomes in this report were not stratified as a function of the type of initial retinal break, so the data are not included in the tables. Another study demonstrated that most detachments that occurred after prophylactic therapy were associated with progression of an incomplete initial PVD.59

Flap tears Horseshoe-shaped tears are mostly responsible for clinical retinal detachment. Symptomatic horseshoe-shaped tears are much more likely to cause retinal detachment than are asymptomatic tears, but many studies have not distinguished between these groups. However, failure of treatment is more common following therapy of symptomatic cases.58 Early failures are usually due to vitreoretinal traction forces that cause an accumulation of subretinal fluid before establishment of an adequate chorioretinal adhesion or to incomplete or inadequate therapy. Treatment should be placed in flat retina immediately adjacent to the location of subretinal fluid, and treatment should extend well anterior to the “horns” of the tear and into the vitreous base (Fig. 106.3).26 However, even optimal therapy may be unsuccessful because of extension of subretinal fluid before an effective chorioretinal adhesion develops. This may be more common following cryotherapy than after laser photocoagulation, because the adhesion forms more quickly after application of the latter method.60

Lattice degeneration There are many difficulties in analyzing results of treatment of lattice degeneration, as mentioned earlier. Results of one study of fellow eyes are listed in Table 106.3. Most new tears following therapy occur in areas not previously treated.

Retinal holes The prognosis for round holes after treatment is substantially better than that for flap tears with persistent vitreoretinal

1803 Chapter 106

indicated. The value of treating other types of retinal breaks and visible vitreoretinal adhesions remains unclear, although effective preventive therapy would be particularly desirable in the second eye of patients with previous retinal detachment in the first eye. Complications of treatment are also difficult to assess. These may include both failure to prevent retinal detachment and pathologic changes caused by the treatment. Some problems that follow therapy may be due to the pathobiology of retinal detachment rather than to genuine treatment complications. Results and selected complications of therapy have been categorized on the basis of the lesion or lesions treated, whereas additional complications have been studied as nonspecific problems.

Prevention of Retinal Detachment

setting is selected and gradually increased until a coagulation effect of the desired intensity is obtained. Applications are usually limited to 0.1–0.15 seconds since longer applications often cause pain. The exact treatment technique varies among surgeons. Some prefer a grid pattern around retinal breaks and other lesions, but most use contiguous applications forming a zone 500–1000 µm wide. All sides of each lesion are treated, with special emphasis on the retina anterior to horseshoe-shaped tears and areas of lattice degeneration where progressive vitreoretinal traction may cause anterior extension of a retinal tear. Discomfort is usually minimal after laser treatment, but a systemic analgesic can be given during the first several hours if treatment was extensive. Activity restrictions depend on the nature of the lesion treated, as described previously for cryotherapy. The coagulative effect of laser treatment seems to cause an effective adhesion more quickly than cryotherapy. Still, patient activity should be limited for a few days if substantial subretinal fluid is present.

1804

Patients with previous retinal detachment in the fellow eye

Surgical Retina

Section 2 Retinal Reattachment: General Surgical Principles and Techniques

traction. As noted earlier, round holes unassociated with persistent vitreoretinal traction or with lattice degeneration are usually not treated.

Fellow eyes of patients with retinal detachment in a first eye have a substantial risk of retinal detachment, and the risk is even higher after cataract extraction. Smiddy et al.58 demonstrated that aphakia and pseudophakia are statistically significant risk factors for failure after prophylactic therapy for retinal breaks. Results of treatment of aphakic fellow eyes in one report are listed in Table 106.4. It is important to note that treatment of the visible lesions in untreated eyes would have prevented few retinal detachments.51

Complications of prophylactic treatment Complications of preventive therapy include failure to prevent retinal detachment, iatrogenic problems increasing the risk of retinal detachment, and other problems caused by treatment, and they have been reviewed in detail elsewhere.27 Retinal detachments that occur despite prophylactic therapy are a result of either an inadequate adhesion around a retinal break or a new retinal break. Extension of the detachment is considered a complication of therapy if the treatment is inadequate in extent or intensity, and a particularly common cause of failure in treating horseshoe-shaped tears is an absence of an adequate chorioretinal adhesion surrounding the anterior margins of the break, where vitreoretinal traction persists.26 New retinal breaks are a complication of prophylactic therapy if the treatment causes excessive damage to the retina, resulting in a break at that location, or if it aggravates vitreous degenerative changes and vitreoretinal traction, causing a tear elsewhere. Epiretinal proliferation that causes macular pucker has been considered an important complication of prophylactic therapy, but the association between treatment and membrane formation is uncertain. Symptomatic retinal tears are almost always due to a posterior vitreous detachment, and a PVD is present in more than 90% of eyes with idiopathic epimacular proliferation.15 Also, when vitreoretinal traction causes a retinal tear, pigment epithelial cells are usually liberated into the vitreous cavity, and these may be a source of subsequent epimacular proliferation. The method of creating a chorioretinal adhesion appears to be unrelated to the incidence of postoperative macular pucker.61

CONCLUSION Although prevention of retinal detachment is an important goal, the genuine value of prophylactic therapy for almost all vitreoretinal lesions remains unknown because of a lack of appropriate trials. Treatment of symptomatic flap tears is an accepted method of preventing clinical retinal detachments, because the natural course of these breaks and the results of therapy are well documented. In most other instances, treatment of visible abnormal vitreoretinal lesions is of limited value, even in eyes with additional risk features such as high myopia, aphakia, or a history of retinal detachment in the fellow eye. The guidelines offered in this chapter represent an attempt to summarize the literature on this topic, and specific decisions regarding prophylaxis for a given eye should be made on the basis of the features of the case and expanding medical knowledge. In the meantime, patients

with high-risk features should be made aware of symptoms of pos­terior vitreous detachment and loss of visual field, and any patient with such symptoms should be promptly evaluated. In addition, periodic follow-up evaluations at the discretion of the examiner may be indicated.

REFERENCES 1. Comer MB, Newman DK, George ND, et al. Who should manage primary retinal detachments? Eye 2000;14:572–8. 2. Minihan M, Tanner V, Williamson TH. Primary retinal detachment: 20 years of change. Br J Ophthalmol 2001;85:546–8. 3. Thompson JA, Snead MP, Billington BM, et al. National audit of the outcome of primary surgery for rhegmatogenous retinal detachment. II. Clinical outcomes. Eye 2002;16:771–7. 4. Asaria RH, Gregor ZJ. Simple retinal detachments: identifying the at-risk case. Eye 2002;16:404–10. 5. Wilkinson CP, Rice TA. Michels retinal detachment, 2nd ed. St Louis: Mosby; 1997. p. 935–77. 6. Byer NE. Rethinking prophylactic therapy of retinal detachment. In: Stirpe M, editor. Advances in vitreoretinal surgery. New York: Ophthalmic Communications Society; 1992. p. 399–411 7. Wilkinson CP. Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment. Cochrane Database Syst Rev 2005;(1):CD003170. 8. Kreis AJ, Aylward GW, Wolfensberger TJ. Prophylaxis for retinal detachment. Evidence or eminence based? Retina 2007;27:466–72. 9. Javitt JC, Tielsch JM, Canner JK, et al. National outcomes of cataract extraction: increased risk of retinal complications associated with Nd:YAG laser capsulotomy. Ophthalmology 1992;99:1487–98. 10. Tielsch JM, Legro MW, Cassard SD, et al. Risk factors for retinal detachment after cataract surgery: a population-based case-control study. Ophthalmology 1996;103:1537–45. 11. Freeman HM. Fellow eye of nontraumatic giant retinal tears. In: Lewis H, Ryan SJ, editors. Medical and surgical retina. St Louis: Mosby; 1994. p. 222–5. 12. Arroyo JG, Postel EA, Stone T, et al. A matched study of primary buckle placement during repair of posterior segment open globe injuries. Br J Ophthalmol 2003;87:75–8. 13. Robertson DM, Priluck IA. 360-degree prophylactic cryo-retinopexy: a clinical and experimental study. Arch Ophthalmol 1979;97:2130–4. 14. Hovland KR. Vitreous findings in fellow eyes of aphakic retinal detachment. Am J Ophthalmol 1978;86:350–3. 15. Sebag J. Myopia effects upon vitreous-significance in retinal detachments. In: Stirpe M, editor. Anterior and posterior segment surgery: mutual problems and common interests. New York: Ophthalmic Communications Society; 1998. 16. Brod RD, Lightman DA, Packer AJ, et al. Correlation between vitreous pigment granules and retinal breaks in eyes with acute posterior vitreous detachment. Ophthalmology 1991;98:1366–9. 17. Byer NE. Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 1994;101:1503–13. 18. Tasman WS. Posterior vitreous detachment and peripheral retinal breaks. Trans Am Acad Ophthalmol Otolaryngol 1968;72:217–24. 19. Tanner V, Harle D, Tan J, et al. Acute posterior vitreous detachment: the predictive value of vitreous pigment and symptomatology. Br J Ophthalmol 2000;84: 1264–8. 20. Shea M, Davis MD, Kamel I. Retinal breaks without detachment, treated and untreated. Mod Probl Ophthalmol 1974;12:97–102. 21. Verdaguer JT, Vaismon M. Treatment of symptomatic retinal breaks. Am J Ophthalmol 1979;87:783–8. 22. Pollack A, Oliver M. Argon photocoagulation of symptomatic flap tears and retinal breaks of fellow eyes. Br J Ophthalmol 1981;65:469–72. 23. Colyear BH, Pischel DK. Preventative treatment of retinal detachment by means of light coagulation. Trans Pac Coast Oto-Ophthalmol Soc 1960;41: 193–215. 24. Robertson DM, Norton EWD. Long-term follow-up of treated retinal breaks. Am J Ophthalmol 1973;75:393–404. 25. Davis MD. The natural history of retinal breaks without detachment. Trans Am Ophthalmol Soc 1973;71:343–72. 26. American Academy of Ophthalmology. Management of posterior vitreous detachment, retinal breaks, and lattice degeneration. Preferred practice pattern. San Francisco: American Academy of Ophthalmology; 1998. 27. Wilkinson CP, Rice TA. Michels retinal detachment, 2nd ed. St Louis: Mosby; 1997, p. 1081–133. 28. Byer NE. Long-term natural history of lattice degeneration of the retina. Ophthalmology 1989;96:1396–401. 29. Burton TC. The influence of refractive error and lattice degeneration on the incidence of retinal detachment. Trans Am Ophthalmol Soc 1989;87: 143–55. 30. Stirpe M, Heimann K. Vitreous changes and retinal detachment in highly myopic eyes. Eur J Ophthalmol 1996;6:50–8. 31. Byer NE. Cystic retinal tufts and their relationship to retinal detachment. Arch Ophthalmol 1981;99:1788–90. 32. Byer NE. Posterior vitreous detachment as a risk factor for retinal detachment. Ophthalmology 1995;102:528–32.

1805 Chapter 106

47. Wolfensberger TJ, Aylward GW, Leaver PK. Prophylactic 360 degree cryotherapy in fellow eyes of patients with spontaneous giant retinal tears. Ophthalmology 2003;110:1175–7. 48. Ang A, Poulsob AV, Goodburn SF, et al. Retinal detachment and prophylaxis in type 1 Stickler syndrome. Ophthalmology 2008;115:164–8. 49. Aylward GW, daCruz L, Sullivan P, et al. Stickler syndrome. Ophthalmology 2008;115:1636–7. 50. Ang GS, Townsend J, Lois N. Interventions for prevention of giant retinal tear in the fellow eye. Cochrane Database Syst Rev 2009;(2):CD006909. 51. Benson WE, Grand MG, Okun E. Aphakic retinal detachment: management of the fellow eye. Arch Ophthalmol 1975;93:245–9. 52. Le Mesurier R, Chignell AH. Prophylaxis of aphakic retinal detachment. Trans Ophthalmol Soc UK 1981;101:212–3. 53. Hudson JR, Kanski JJ. Prevention of aphakic retinal detachment by circumferential cryotherapy. Mod Probl Ophthalmol 1977;18:530–7. 54. Laidlaw DA, Karia N, Bunce C, et al. Is prophylactic 360-degree laser retinopexy protective? Risk factors for retinal detachment after removal of silicone oil. Ophthalmology 2002;109:153–8. 55. Avitabile T, Longo A, Lentmig G, et al. Retinal detachment after silicone oil removal is prevented by 360 degrees laser treatment. Br J Ophthalmol 2008; 92:1479–82. 56. Koh HK, Cheng L, Kosobucki B, et al. Prophylactic intraoperative 360 degree laser retinopexy for prevention of retinal detachment. Retina 2007;27:744–9. 57. Tornambe PE. Pneumatic retinopexy: the evolution of case selection and surgical technique. A twelve-year study of 302 eyes. Trans Am Ophthalmol Soc 1997;95:551–78. 58. Smiddy WE, Flynn HW, Nicholson DH, et al. Results and complications in treated retinal breaks. Am J Ophthalmol 1991;112:623–31. 59. Mastropasqua L, Carpineto P, Ciancaglini M, et al. Treatment of retinal tears and lattice degeneration in fellow eyes in high risk patients suffering retinal detachment: a prospective study. Br J Ophthalmol 1999;83:1046–9. 60. Folk JC, Sneed SR, Folberg R, et al. Early retinal adhesion from laser photocoagulation. Ophthalmology 1989;96:1523–5. 61. Saran BR, Brucker AJ. Macular epiretinal membrane formation and treated retinal breaks. Am J Ophthalmol 1995;120:480–5.

Prevention of Retinal Detachment

33. Byer NE. Long-term natural history study of senile retinoschisis with implications for management. Ophthalmology 1986;93:1127–37. 34. Hagler WS, Waldoff HS. Retinal detachment in relation to senile retinoschisis. Trans Am Acad Ophthalmol Otolaryngol 1973;77:99–111. 35. Byer NE. What happens to untreated asymptomatic retinal breaks and are they affected by posterior vitreous detachment? Ophthalmology 1998;105: 1045–9. 36. Sigelman J. Vitreous base classification of retinal tears: clinical application. Surv Ophthalmol 1980;25:59–74. 37. The Eye Disease Case–Control Study Group. Risk factors for idiopathic rhegmatogenous retinal detachment. Am J Epidemiol 1993;137:749–57. 38. Folk JC, Arrindell EL, Klugman MR. The fellow eye of patients with phakic lattice retinal detachment. Ophthalmology 1989;96:72–9. 39. Norregaard JC, Thoning H, Andersen TF, et al. Risk of retinal detachment following cataract extraction: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol 1996;80:689–93. 40. Friedman Z, Neumann E, Hyams SW. Vitreous and peripheral retina in aphakia: a study of 200 non-myopic aphakic eyes. Br J Ophthalmol 1973;57: 52–7. 41. Hyams SW, Neumann E, Friedman Z. Myopia-aphakia. II. Vitreous and peripheral retina. Br J Ophthalmol 1975;59:483–5. 42. Folk JC, Bennet SR, Klugman MR, et al. Prophylactic treatment to the fellow eye of patients with phakic lattice retinal detachment: analysis of failures and risks of treatment. Retina 1990;10:165–9. 43. Haut J, Ladjimi A, Van Effenterre G, et al. Preventative treatment of retinal detachment of the contralateral eye: results of 5 years of follow-up of 109 eyes. J Fr Ophtalmol 1991;14:397–404. 44. Monin C, Van Effenterre G, Andre-Sereys P, et al. Prevention of retinal detachment in Wagner-Stickler disease: comparative study of different methods. J Fr Ophtalmol 1994;17:167–74. 45. Merin S, Feiler V, Hyams S, et al. The fate of the fellow eye in retinal detachment. Am J Ophthalmol 1971;71:477–81. 46. Michaelson IC, Stein R, Neumann E, et al. A national cooperative study in the prevention of retinal detachment. In: Pruett RC, Regan CD, editors. Retina congress. New York: Appleton-Century-Crofts; 1974.